News and Updates

Explore the Latest from Sensus Healthcare

Discover the latest top news articles from Sensus Healthcare. Stay informed about our groundbreaking advancements, treatment breakthroughs, and industry insights. Explore our curated selection of articles and navigate through them using the pagination feature below

Summer, Sun, and Skin: SRT as the Future of Non-Invasive Skin Cancer Treatments

Ranking the 7 Best Treatments for Non-Melanoma Skin Cancer

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

Sensus Healthcare Announces Sale of First SRT-100 Visionâ„¢ System to Asia

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

Superficial Radiotherapy: The Perfect Option for Treating Keloids

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.